Zynex, Inc. engages in the design, manufacture, and marketing of medical devices. The company is headquartered in Englewood, Colorado and currently employs 1,000 full-time employees. The company went IPO on 2002-11-27. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave, M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Private Labeled Rehabilitation Products, which include Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces, Bracing (Knee and Wrist), and Dynacomp, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter.
How did ZYXI's recent EPS compare to expectations?
The most recent EPS for Zynex Inc is $, expectations of $.
How did Zynex Inc ZYXI's revenue perform in the last quarter?
Zynex Inc revenue for the last quarter is $
What is the revenue estimate for Zynex Inc?
According to of Wall street analyst, the revenue estimate of Zynex Inc range from $ to $
What's the earning quality score for Zynex Inc?
Zynex Inc has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Zynex Inc report earnings?
Zynex Inc next earnings report is expected in
What are Zynex Inc's expected earnings?
Zynex Inc expected earnings is $, according to wall-street analysts.